Literature DB >> 20571742

[High glucose increases periostin expression and the related signal pathway in adult rat cardiac fibroblasts].

Ping Zou1, Li-Ling Wu, Dan Wu, Dong Fan, Xiao-Bing Cui, Yun Zhou, Cheng Wang, Li Li.   

Abstract

Cardiac fibrosis is a major mechanism contributing to myocardial systolic and diastolic dysfunction in diabetic cardiomyopathy. Periostin is a novel extracellular matrix protein, secreted from cardiac fibroblasts, and closely related with cardiac fibrosis and remodeling. The present study aimed to investigate the effect of high glucose on periostin expression and the related signal transduction pathway in cardiac fibroblasts. Adult rat cardiac fibroblasts were cultured and stimulated with high glucose (25 mmol/L). The mRNA and protein expressions of periostin were detected by RT-PCR and Western blot, respectively. Intracellular reactive oxygen species (ROS) production was measured using 2, 7-dichlorofluorescein diacetate (DCF-DA), an oxidant-sensitive fluorescent probe. Results showed that the mRNA expression of periostin in adult rat cardiac fibroblasts was increased by 117.26% when treated with high glucose for 12 h. Incubation with high glucose for 24 h enhanced periostin protein expression by up to 93.12%. High glucose induced the production of ROS in adult rat cardiac fibroblasts, which was reduced by chelerythrine (CLT), a protein kinase C (PKC) inhibitor. High glucose-induced periostin protein expression was decreased significantly when pretreated with CLT or N-acetylcysteine (NAC), a ROS scavenger. The phosphorylation of c-jun N-terminal protein kinase (JNK) was increased markedly when stimulated with high glucose for 30 and 60 min, which was abolished when pretreated with CLT or NAC. SP600125, a specific JNK inhibitor, significantly decreased periostin expression induced by high glucose. In conclusion, high glucose stimulates periostin protein expression via a PKC/ROS/JNK-dependent pathway in adult rat cardiac fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571742

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  4 in total

1.  Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis.

Authors:  Niko Braun; Kontheari Sen; M Dominik Alscher; Peter Fritz; Martin Kimmel; Johann Morelle; Eric Goffin; Achim Jörres; Rudolf P Wüthrich; Clemens D Cohen; Stephan Segerer
Journal:  Perit Dial Int       Date:  2013-02-01       Impact factor: 1.756

2.  Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.

Authors:  Chun-jun Li; Lin Lv; Hui Li; De-min Yu
Journal:  Cardiovasc Diabetol       Date:  2012-06-19       Impact factor: 9.951

3.  Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.

Authors:  Han Wu; Guan-Nan Li; Jun Xie; Ran Li; Qin-Hua Chen; Jian-Zhou Chen; Zhong-Hai Wei; Li-Na Kang; Biao Xu
Journal:  BMC Cardiovasc Disord       Date:  2016-01-11       Impact factor: 2.298

4.  Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan.

Authors:  Jun Guan; Wen-Qi Liu; Ming-Qing Xing; Yue Shi; Xue-Ying Tan; Chang-Qing Jiang; Hong-Yan Dai
Journal:  BMC Cardiovasc Disord       Date:  2015-08-18       Impact factor: 2.298

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.